Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 9:27am ET
 -0.34 / -0.62%
Today’s Change
Today|||52-Week Range
The Zacks Analyst Blog Highlights: Zoetis, McKesson, Merck, Endo International and Am...
10:04am / Zacks.com
Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact
Apr 29 / Zacks.com
3 Dirt-Cheap Biotech Stocks To Buy
8:14am / MotleyFool.com
9 Figures That Sum Up Gilead Sciences' First Quarter
Apr 28 / MotleyFool.com
5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report
May 03 / MotleyFool.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
Drug Stocks Reporting Mid-Week: MRK, ABC, ENDP & More
May 03 / Zacks.com
3 Healthcare Stocks Billionaires Love Right Now
Apr 28 / MotleyFool.com
Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys
May 03 / MotleyFool.com
UnitedHealths Obamacare Changes to Affect Healthcare Sector
Apr 27 / GuruFocus News
Good News: Gilead Sciences Discounted Its Drugs Again
May 02 / MotleyFool.com
Today's Top Performers In Health Care
Apr 27 / TheStreet.com
Merck (MRK) Q1 Earnings: Can the Stock Pull a Surprise?
May 02 / Zacks.com
4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG
Apr 27 / Zacks.com
Don't Give Up on Gilead Following a Weak Q1
May 02 / TheStreet.com
5 Stocks With Bigger Dividends Than Merck & Co.
Apr 25 / MotleyFool.com
Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?
May 02 / TheStreet.com
Healthcare Q1 Earnings Look Solid: ETFs to Benefit
Apr 25 / Zacks.com
Slew Of Negative News, Defaults And Failed Mergers Push Futures In The Green
May 02 / Investing Channel
Vaccine development needs global alliance
Apr 24 / FT.com
What Does It Take to Outperform the S&P 500? We Asked a Board Member Who Does It
Apr 30 / TheStreet.com
Vaccines are among big pharma's best-selling products
Apr 24 / FT.com
Apple Drives Selloff on April's Last Trading Day
Apr 29 / TheStreet.com
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com
Stocks Sell Off in Final Trading Day of April
Apr 29 / TheStreet.com
Roche 'very optimistic' on prospects for new cancer drugs
Apr 19 / FT.com
Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales
Apr 29 / MotleyFool.com